← Leaderboards
Ravirajsinh Jadeja
Hillhurst Biopharmaceuticals, Inc.
$1,122,113
Attributed
$2,596,339
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,596,339 · 3
By mechanism
R44$1,911,440 · 1
R56$385,000 · 1
R41$299,899 · 1
Top collaborators
- Edward Gomperts3 shared
- Pamela M Martin3 shared
Most similar at Hillhurst Biopharmaceuticals, Inc.
Same institution · by research overlap
- Edward Gomperts$8,146,154
- John D Belcher$2,490,337
Others in their field
Other Emerging Leaders on “Retinal Diseases”
- Ionut Bebu · George Washington University$14,785,800
- Barbara Halina Braffett · George Washington University$14,785,800
- Jessica Alber · University Of Rhode Island$8,807,713
- Ruchira Singh · University Of Rochester$7,225,302
- Bryan William Jones · Utah State Higher Education System--University Of Utah$7,081,756
- Bradley David Gelfand · University Of Virginia$6,668,467
Research focus
Retinal DiseasesBlindnessPhenotypeTreatment EfficacyMonitorHyperglycemiaInflammationOralRetinaAffectBlood VesselsPreventIschemiaElderlyClinical ResearchEndothelial CellsDrug KineticsClinical TrialsEfficacy EvaluationEventBiochemicalDiabetes MellitusDiabetic MouseCarbon Monoxide